Core Acquisition Overview - CoreWeave has made a $9 billion all-stock bid for Core Scientific, which has led to a nearly 18% drop in Core Scientific's shares following the announcement [1] - The shareholder vote on the acquisition is scheduled for October 30, with increasing opposition from various stakeholders [2] CoreWeave's Position - CoreWeave CEO Michael Intrator has stated that the acquisition is viewed as optional, emphasizing that the price will not increase despite shareholder pushback [2][3] - Intrator described Core Scientific as "a nice to have, not a need to have," indicating CoreWeave's willingness to abandon the deal if rejected by shareholders [3][5] Shareholder Opposition - Institutional Shareholder Services and Glass Lewis have both recommended that Core Scientific shareholders reject the acquisition, citing concerns over the offer's value [5] - Two Seas Capital, a significant investor in Core Scientific, has also urged a vote against the acquisition, labeling it "underwhelming" based on the company's recent trading performance [5] Strategic Considerations - CoreWeave has countered criticisms from shareholder advisory firms, arguing that their focus on short-term stock performance overlooks the strategic risks Core Scientific may face if it remains independent [4]
This Bitcoin Miner's Shareholders May Reject A $9B Buyout—And the CEO Says He Won't Budge on Price